Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial
- PMID: 8606274
- DOI: 10.1016/0735-1097(95)00513-7
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial
Abstract
Objectives: This study sought to readdress the definition of uncomplicated myocardial infarction and to apply clinical criteria for early discharge of such patients in the thrombolytic era.
Background: Previous studies proposed early hospital discharge at day 7 to 10 after acute myocardial infarction. The potential for earlier discharge of patients with uncomplicated infarction after thrombolysis remains undemonstrated.
Methods: We defined "uncomplicated infarction" a priori as the absence of death, reinfarction, ischemia, stroke, shock, heart failure (Killip class > 1), bypass surgery, balloon pumping, emergency catheterization or cardioversion or defibrillation in the first 4 hospital days. We applied this definition to 41,021 patients in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO-I) trial. We examined death at 30 days and 1 year and rates of in-hospital reinfarction, heart failure, recurrent ischemia, shock and stroke in the uncomplicated and complicated groups created by application of our definition. We also assessed lengths of hospital and cardiac care unit stay.
Results: Application of our clinical criteria yielded 23,497 (57.3%) patients in the uncomplicated group at day 4 with a very low risk of death and in-hospital complications: 30-day mortality 1%, reinfarction 1.7%, heart failure 2.6%, recurrent ischemia 6.7%, shock 0.4% and stroke 0.2%. One-year mortality was 3.6%. The median hospital stay was 9 days (7, 12 [25th, 75th percentiles, respectively]), and the median cardiac care unit stay 3 days (3, 5).
Conclusions: Simple clinical characteristics can identify a very low risk post-myocardial infarction population by hospital day 4. Use of these criteria for early discharge planning could substantially reduce length of stay for patients with uncomplicated acute myocardial infarction.
Similar articles
-
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.Circulation. 2001 Sep 11;104(11):1229-35. doi: 10.1161/hc3601.095717. Circulation. 2001. PMID: 11551872
-
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.J Am Coll Cardiol. 1997 Jul;30(1):171-9. doi: 10.1016/s0735-1097(97)00118-6. J Am Coll Cardiol. 1997. PMID: 9207639 Clinical Trial.
-
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.Am J Cardiol. 1996 Dec 15;78(12):1338-44. doi: 10.1016/s0002-9149(96)00654-6. Am J Cardiol. 1996. PMID: 8970403
-
Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.J Accid Emerg Med. 1999 Nov;16(6):407-11. doi: 10.1136/emj.16.6.407. J Accid Emerg Med. 1999. PMID: 10572811 Free PMC article. Review.
-
Thrombolytic therapy in Europe: current status.Eur Heart J. 1996 Sep;17 Suppl E:21-7. doi: 10.1093/eurheartj/17.suppl_e.21. Eur Heart J. 1996. PMID: 11824000 Review.
Cited by
-
Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.Pharmacoeconomics. 1996 Sep;10(3):281-310. doi: 10.2165/00019053-199610030-00009. Pharmacoeconomics. 1996. PMID: 10163575 Review.
-
Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction.Heart. 2001 Apr;85(4):417-23. doi: 10.1136/heart.85.4.417. Heart. 2001. PMID: 11250968 Free PMC article.
-
Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial.Am Heart J. 2009 Apr;157(4):666-72. doi: 10.1016/j.ahj.2008.12.004. Epub 2009 Feb 23. Am Heart J. 2009. PMID: 19332193 Free PMC article. Clinical Trial.
-
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.Am Heart J. 2018 Jul;201:103-110. doi: 10.1016/j.ahj.2018.04.010. Epub 2018 Apr 20. Am Heart J. 2018. PMID: 29910048 Free PMC article. Clinical Trial.
-
Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions.Am J Med. 2010 Nov;123(11):1007-15. doi: 10.1016/j.amjmed.2010.05.018. Am J Med. 2010. PMID: 21035590 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical